Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers

Clinical and Vaccine Immunology

Volumn 13, Issue 9, 2006, Pages 1052-1056

  Toraño, Gilda ^a   Toledo, Maria E ^a   Baly, Alberto ^a   Fernandez Santana, Violeta ^c   Rodriguez, Francisco ^a   Alvarez, Yunia ^a   Serrano, Teresita ^a   Musachio, Alexis ^b   Hernandez, Ibis ^a   Hardy, Eugenio ^b   Rodríguez, Arlene ^b   Hernandez, Hector ^b   Aguilar, Aristides ^b   Sánchez, Raydel ^a   Diaz, Manuel ^a   Muzio, Verena ^b   Dfana, Jorgelina ^a   Rodríguez, Maria C ^c   Heynngnezz, Lazaro ^b   Verez Bencomo, Vicente ^c  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^c UNIVERSITY OF HAVANA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOSACCHARIDE; VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ERYTHEMA; FEASIBILITY STUDY; FEVER; HAEMOPHILUS INFLUENZAE TYPE B; HEADACHE; HUMAN; IMMUNOGENICITY; INFLAMMATION; INJECTION SITE PAIN; MALAISE; MALE; NORMAL HUMAN; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWELLING; VACCINE PRODUCTION;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; RETROSPECTIVE STUDIES; SERUM BACTERICIDAL TEST; VACCINES, CONJUGATE;

EID: 33749488093     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00144-06     Document Type: Article

References (24)

1. Adams, W. G., K. A. Deaver, S. L. Cochi, B. D. Plikajtis, E. R. Zell, C. V. Broome, and J. D. Wenger. 1993. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 269:221-226.
2. Chong, P., N. Chan, A. Kandil, B. Triplet, O. James, Y. P. Yang, S. P. Shi, and M. Klein. 1997. A strategy for rational design of fully synthetic glycopeptide conjugate vaccines. Infect. Immun. 65:4918-4925.
3. Eskola, J., H. Kayhty, A. Takala, H. Peltola, P. Ronnberg, E. Kela, E. Pokkanen, P. McVerry, and P. Makela. 1990. A randomized, prospective field of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N. Engl. J. Med. 323:1381-1387.
4. Fernández-Santana, V., F. Cardoso, A. Rodriguez, T. Carmenate, L. Peña, Y. Valdés, E. Hardy, F. Mawas, L. Heynngnezz, M. C. Rodríguez, I. Figueroa, J. Chang, M. E. Toledo, A. Musacchio, I. Hernández, M. Izquierdo, K. Cosme, R. Roy, and V. Verez-Bencomo. 2004. Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b. Infect. Immun. 72:7115-7123.
5. Giswold, W. R., A. H. Lucas, J. F. Bastian, and G. Garcia. 1989. Functional affinity of antibody to the Haemophilus influenzae type b polysaccharide. J. Infect. Dis. 159:1083-1087.
6. Granoff, S. D., E. G. Boies, and R. S. Munson. 1984. Immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in adults. J. Pediatr. 105:22-27.
7. Hornick, C. L., and F. Karush. 1972 Antibody affinity: the role of multivalence. Immunochemistry 9:325-340.
8. Kayhty, H., J. Eskola, and H. Peltola. 1991. Antibody response to four Haemophilus influenzae type b conjugate vaccines. Am. J. Dis. Child. 145:223-227.
9. Kayhty, H., J. Eskola, H. Peltola, M. Stout, J. Samuelson, and L. Gordon. 1987. Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid. J. Infect. Dis. 155:100-106.
10. Kayhty, H., H. Peltola, and J. Eskola. 1998. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children. Pediatr. Infect. Dis. J. 7:574-577.
11. Lepow, M. L., J. S. Samuelson, and L. K. Gordon. 1984. Safety and immunogenicity of Haemophilus influenzae type b diphtheria toxoid conjugate vaccine in adults. J. Infect. Dis. 150:402-406.
12. Myerowitz, R. L., Z. T. Handzel, R. Schneerson, and J. B. Robbins. 1973. Induction of Haemophilus influenzae type b capsular antibody in neonatal rabbits by gastrointestinal colonization with cross-reacting Escherichia coli. Infect. Immun. 7:137-140.
13. Nilsson, S., M. Bengtsson, and T. Norberg. 1992. Solid-phase synthesis of a fragment of the capsular polysaccharide of Haemophilus influenzae using H-phosphonate intermediates. J. Carbohydr. Chem. 11:265-285.
14. Peeters, C. C., D. Evenberg, P. Hoogechout, H. Kayhty, L. Saarinen, C. A. van Boeckel, G. A. van der Marel, J. H. van Boom, and J. T. Poolman. 1992. Synthetic trimer and tetramer of 3-β-D-ribose-(1-1)-D-ribitol-phosphate conjugated to protein induce antibody responses to Haemophilus influenzae type b capsular polysaccharide in mice and monkeys. Infect. Immun. 60:1826-1833.
15. Peltola, H. 2000. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st Century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 13:302-317.
16. Peltola, H., T. Kilpi, and M. Antilla. 1992. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines. Lancet 340:592-594.
17. Phipps, D., J. West, R. Eby, M. Koster, D. Madore, and S. Kuataert. 1990. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J. Immunol. Methods 135:121-128.
18. Romero-Steiner, S., J. Fernandez, C. Biltoft, M. E. Wohl, J. Sanchez, J. Feris, S. Balter, O. S. Levine, and G. M. Carlone. 2001. Functional antibody activity elicited by fractional doses of Haemophilus influenzae Type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate). Clin. Diagn. Lab. Immunol. 8:1115-1119.
19. Schneerson, R., J. Robbins, J. Parke, C. Bell, J. Schlesselman, A. Sutton, Z. Wang, G. Schiffman, A. Karpas, and J. Shiloach. 1986. Quantitative and qualitative analysis of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect. Immun. 52:519-528.
20. Schneerson, R., and J. B. Robbins. 1975. Induction of serum Haemophilus influenzae type b capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5. N. Engl. J. Med. 292:1093-1096.
21. Schneerson, R., L. P. Rodrigues, J. C. Parke, and M. Robbins. 1971. Immunity to disease caused by Haemophilus influenzae type b. Specific and some biologic characteristics of natural, infection acquired, and immunization induced antibodies to the capsular polysaccharide of Haemophilus influenzae type b. Immunology 108:1551-1562.
22. Slack, M. P. E. 1995. Invasive Haemophilus influenzae disease: the impact of Hib immunization. J. Med. Microbiol. 42:75-77.
23. Steinhoff, M. C. 1997. Haemophilus influenzae type b infections are preventable everywhere. Lancet 349:1186-1187.
24. Vérez-Bencomo, V., V. Fernández-Santana, E. Hardy, M. E. Toledo, M. C. Rodríguez, L. Heynngnezz, A. Rodríguez, A. Baly, L. Herrera, M. Izquierdo, A. Villar, Y. Valdés, K. Cosme, M. Deler, M. Montane, E. García, A. Ramos, A. Aguilar, E. Medina, G. Toraño, I. Sosa, I. Hernández, R. Martínez, A. Muzachio, A. Carmenates, L. Costa, F. Cardoso, C. Campa, M. Díaz, and R. Roy. 2004. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science 35:522-525.